Memorial Sloan Kettering Cancer Center Program

Program Identity & Fit

Memorial Sloan Kettering's radiation oncology residency is a quaternary, cancer-only academic program embedded in one of the world's highest-volume comprehensive cancer centers, exposing residents to the full breadth of modern technique - proton therapy, radiosurgery, brachytherapy, intraoperative RT, total body and total skin electron beam irradiation - alongside close collaboration with surgical and medical oncology. Research is structurally central: every resident receives a dedicated, protected research year (typically PGY-3) embedded in MSK's Human Oncology and Pathogenesis Program and Sloan Kettering Institute laboratories, and a formal ABR Holman Research Pathway exists for residents committed to physician-scientist careers, with current trainees holding MD/PhDs and pursuing computational oncology, cancer metabolism, and clonal hematopoiesis projects. The resident cohort is overwhelmingly composed of MD/PhDs and dual-degree trainees with prior transitional-year internships at MSK itself, publication records in high-impact journals, and named research mentors, signaling a program built to produce academic leaders and independent investigators rather than generalist community practitioners. Distinctive features include a large 24-resident cohort with 57 faculty, a single shared residents' room fostering cohesion, and near-universal continuation of resident research into junior faculty positions.